Skip to content

Analysis of anti-NAE antibodies and new autoantibodies in neurological disorders

Analysis of anti-NAE antibodies and new autoantibodies in neurological disorders - Analysis of autoantibodies in neurological disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030302
Enrollment
450
Registered
2017-12-07
Start date
2017-11-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological disorders

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Multiple system atrophy; Second consensus criteria (2008), Parkinson's disease; United Kingdom Parkinson's disease Brain Bank criteria (1998), Dementia with Lewy bodies; Diagnosis criteria by McKeith (2005), Progressive supranuclear palsy; Diagnosis criteria by NINDS-SPSP International Workshop (1996), Corticobasal syndrome; Modified Cambridge criteria (2012), Alzheimer's disease; Diagnosis criteria by National Institute of Aging (NIA) / Alzheimer Association (AA) (2011), Frontotemporal lobar degeneration; Diagnosis criteria by Neary (1998)

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

MeasureTime frame
Presence of anti-NAE antibodies in neurological disorders

Countries

Japan

Contacts

Public ContactAkio Kikuchi

Tohoku University Graduate School of Medicine Department of Neurology

akikuchi@med.tohoku.ac.jp022-717-7189

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026